Skip to Content

Veramyst Approval History

  • FDA approved: Yes (First approved April 27th, 2007)
  • Brand name: Veramyst
  • Generic name: fluticasone furoate
  • Dosage form: Nasal Spray
  • Company: GlaxoSmithKline
  • Treatment for: Allergic Rhinitis

Veramyst (fluticasone furoate) is an intranasal corticosteroid administered once-daily for the treatment of seasonal and year- round allergy symptoms in adults and children two years of age and older.

Development History and FDA Approval Process for Veramyst

Apr 29, 2007Approval FDA Approves Once-Daily Veramyst (fluticasone furoate) Nasal Sprayfor Treatment of Seasonal and Year-Round Allergy Symptoms in Adultsand Children as Young as Two Years
Jul 27, 2006New Seasonal and Perennial Rhinitis Intranasal Treatment Submitted for U.S. and European Marketing Approval

Disclaimer: Every effort has been made to ensure that the information provided here is accurate, up-to-date and complete, but no guarantee is made to that effect. Drug information contained herein may be time sensitive. This information has been compiled for use by healthcare practitioners and consumers in the United States. The absence of a warning for a given drug or combination thereof in no way should be construed to indicate that the drug or combination is safe, effective or appropriate for any given patient. If you have questions about the substances you are taking, check with your doctor, nurse or pharmacist.